Lisinopril 5mg tablets

Pajjiż: Ingilterra

Lingwa: Ingliż

Sors: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ixtrih issa

Ingredjent attiv:

Lisinopril

Disponibbli minn:

Zentiva Pharma UK Ltd

Kodiċi ATC:

C09AA03

INN (Isem Internazzjonali):

Lisinopril

Dożaġġ:

5mg

Għamla farmaċewtika:

Oral tablet

Rotta amministrattiva:

Oral

Klassi:

No Controlled Drug Status

Tip ta 'preskrizzjoni:

Valid as a prescribable product

Sommarju tal-prodott:

BNF: 02050501; GTIN: 5000283630654

Fuljett ta 'informazzjoni

                                Package Leaflet: Information for the User
ZESTRIL
® 5MG TABLETS
(LISINOPRIL)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same
as
yours.

If you get any side effects, talk to your doctor or pharmacist.
This includes any possible side effects not listed in this leaflet.
See section 4.

The name of this medicine is Zestril
®
5mg Tablets but will be referred
to as Zestril throughout the remainder of this leaflet.

Zestril is also available in other strengths.
WHAT IS IN THIS LEAFLET:
1. What Zestril is and what it is used for
2. What you need to know before you take Zestril
3. How to take Zestril
4. Possible side effects
5. How to store Zestril
6. Contents of the pack and other information
1. WHAT ZESTRIL IS AND WHAT IT IS USED FOR
Zestril contains a medicine called lisinopril. This belongs to a group
of
medicines called ACE inhibitors.
Zestril can be used for the following conditions:

To treat high blood pressure (hypertension).

To treat heart failure.

If you have recently had a heart attack (myocardial infarction).

To treat kidney problems caused by Type II diabetes in people with
high blood pressure.
Zestril works by making your blood vessels widen. This helps to lower
your blood pressure. It also makes it easier for your heart to pump
blood
to all parts of your body.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ZESTRIL
DO NOT TAKE ZESTRIL:

if you are allergic to lisinopril or any of the other ingredients of
this
medicine (listed in section 6).

if you have ever had an allergic reaction to another ACE inhibitor
medicine. The allergic reaction may have caused swelling of the
hands, feet, ankles, face, lips, tongue or throat. It may also have
made
it 
                                
                                Aqra d-dokument sħiħ
                                
                            

Karatteristiċi tal-prodott

                                1
NAME OF THE MEDICINAL PRODUCT
LISINOPRIL 5mg TABLETS
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 5mg of Lisinopril as Lisinopril dihydrate.
For the full list excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet
White, round, flat 8 mm tablets, scored on both sides.
The tablet can be divided into equal halves.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
•
Hypertension: Treatment of hypertension.
•
Heart failure: Treatment of symptomatic heart failure.
•
Acute myocardial infarction: Short-term (6 weeks) treatment of
haemodynamically
stable patients within 24 hours of an acute myocardial infarction.
•
Renal complications of diabetes mellitus: Treatment of renal disease
in hypertensive
patients with Type 2 diabetes mellitus and incipient nephropathy (see
section 5.1).
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
POSOLOGY
Lisinopril should be administered orally in a single daily dose. As
with all other medication
taken once daily, lisinopril should be taken at approximately the same
time each day. The
absorption of lisinopril tablets is not affected by food.
The dose should be individualised according to patient profile and
blood pressure response
(see section 4.4).
HYPERTENSION
Lisinopril may be used as monotherapy or in combination with other
classes of
antihypertensive medicinal products (see sections 4.3, 4.4, 4.5 and
5.1).
•
Starting dose
In patients with hypertension the usual recommended starting dose is
10mg. Patients with a
strongly activated renin-angiotensin-aldosterone system (in
particular, renovascular
hypertension, salt and or volume depletion, cardiac decompensation, or
severe hypertension)
may experience an excessive blood pressure fall following the initial
dose. A starting dose
of 2.5-5mg is recommended in such patients and the initiation of
treatment should take place
under medical supervision. A lower starting dose is required in the
presence of renal
impairment (see Table 1 below).
•
Maintenance dose
The usual effective maintenance dosage is 20mg admin
                                
                                Aqra d-dokument sħiħ
                                
                            

Fittex twissijiet relatati ma 'dan il-prodott